Health Claim For Anxiety Reduction Among Latest EU Rejections
Executive Summary
The health claim “Affron contributes to maintain a healthy mood by reducing the negative traits of depressive and anxiety feelings” is one of four rejected by the European Commission in the first half of 2023.
You may also be interested in...
EU Authorizes Cholesterol Lowering Health Claim For Supplement After 10 Year Wait
France's Laboratoire Lescuyer can now claim its Limicol botanical extract supplement "reduces blood LDL-cholesterol concentrations" after waiting more than 10 years for approval by the European Commission.
EU Rejects 8 Health Claims For Foods In 2022, Authorizes None
Five general function health claims, two for the reduction of disease risk and one for children's development or health were rejected by the European Commission in 2022 after applicants failed to establish a cause and effect relationship between the food and the claimed effect.
Nestlé Partner Valbiotis Hails Trial Results For Prediabetes Supplement
Valbiotis and Nestlé Health Science plan to launch in 2024 a dietary supplement targeted at sufferers of prediabetes and type-2 diabetes following positive results from a recent study which showed the product's efficacy on key markers of glucose metabolism.